Drug company to give lifesaving medication to 7-year-old boy - New York News

Drug company to give lifesaving medication to 7-year-old boy

Posted: Updated:
By FOX NEWS -

UPDATE:

A pharmaceutical company that produces medication needed to save a dying 7-year-old boy will begin a pilot trial for the drug – with the child to be the program’s first patient beginning on Wednesday, the firm said Tuesday night.

The announcement comes after the company, Chimerix, faced intense media scrutiny after it reportedly denied the medication brincidofovir to Josh Hardy, a Fredericksburg, Va. boy who developed a bone marrow disorder as a result of his cancer treatments late last year.

At one point, CEO Kenneth I. Moch had been accused of hanging up in a phone call from a representative from a charity that had offered to pay for the medication.

However, Moch said in a statement Tuesday night that the company would provide the much-needed drug.

"This 20-patient open-label study underscores Chimerix's mission to develop innovative antiviral therapies in areas of high unmet need -- for everyone," Moch said. "Being unable to fulfill requests for compassionate use is excruciating, and not a decision any one of us ever wants to have to make. It is essential that each individual in a health crisis be treated with equal gravity and value, a principle we have upheld by pursuing further clinical study of brincidofovir that will inform its use in adenovirus and other serious DNA viral infections."

Through a grassroots campaign launched by Josh’s mother, Chimerix had received hundreds of phone calls and emails in support of Josh, and the hashtag #savejosh had been trending on Twitter. Supporters even chartered buses so they could protest at the company’s headquarters.

Although support for Josh is strong, Hardy’s mother, Aimee Hardy, has said her son is running out of time.

“It’s horrible for us as parents to see, because he’s a vibrant, strong little boy, and even though he is frail, he has a very strong will about him,” Hardy told Fox News. “But things just keep stacking against him, and we just want to do everything we can to give him the opportunity to make a full recovery.”

Dr. Robert Hariri, the CEO of the biotechnology company Celgene, told FoxNews.com on Tuesday that colleagues in the industry "look to a company like Chimerix to provide an example of being heroic in these situations for the best interest of society."

"We all run into problems where potentially life-saving therapies which are in development and under investigation are called upon by people who have no other choices, and who will die whether they receive the experimental therapy or not," he said. "And we’re often facing the very complicated decisions on whether to potentially jeopardize the development of a drug or product because there’s need for compassionate use.”


Previous version of story:

Seven-year-old Josh Hardy has survived four bouts of kidney cancer, heart failure and a bone marrow transplant. But now, he is fighting for his life once again, after a drug company denied him access to a medication that could cure him of a potentially deadly virus.

In an attempt to save her son’s life, Josh’s mother, Aimee Hardy, has launched a grassroots campaign to encourage drug manufacturer Chimerix to allow her son to have the medication he so desperately needs.

“I want to be by his bedside, holding his hand, telling him, ‘It’s going to be okay,’ but because of this unwillingness to release this drug, I have to leave him and come talk to you and it infuriates me,” Hardy, from Fredericksburg, Va., told Peter Johnson Jr. on Fox and Friends.

Josh had been cancer-free for two years when a bone scan in November 2013 revealed he had developed a bone marrow disorder as a result of his earlier cancer treatments. In January 2014, he underwent chemotherapy and a bone marrow transplant at St. Jude Children’s Research Hospital in Memphis, Tenn., but he subsequently developed adenovirus – an acute infection that can be deadly in people with compromised immune systems.

“Normally, Josh’s immune system would be able to handle the adenovirus if his immune system was set free,” Hardy wrote on her son’s CaringBridge.org page. “The challenge is his immune system can’t be set free yet because his body is still trying to adapt to the new bone marrow cells. So to keep the body from killing the new cells, they have to suppress the immune system, thus creating ideal conditions for adenovirus to advance. Catch 22.”

Doctors at St. Jude recommended Josh be treated with Brincidofovir – an antiviral drug that has been proven to clear up adenovirus in children within two weeks. However, Brincidofovir has not yet been approved by the FDA, so Josh hasn’t been able to gain access to the medication.

Chimerix, the company that manufactures Brincidofovir, has given hundreds of patients emergency access to the medication in the past, but they have since stopped this practice saying ‘they cannot afford it,’ according to Johnson Jr. However, Chimerix has received more than $72 million in federal funding to develop Brincidofovir.

“As we progressed to larger and more complex safety trials, we made the decision two years ago to stop the program and focus resources on earning FDA approval,” said Kenneth Moch, the CEO of Chimerix.

As Josh’s health continues to worsen, the Hardy family has launched a campaign to convince the company to allow Josh to receive the drug through a ‘compassionate use’ program – in which a drug company can allow a seriously ill patient to receive access to an unapproved drug.

“I feel that it’s just an excuse and we need them to totally change their stance, not only for us but for hundreds or even thousands of people that need [this drug],” Hardy told Fox and Friends. “…To me, [it’s] almost a crime to not make it available to everyone who needs it.”

Moch said his company has received hundreds of phone calls and emails in support of Josh. A Twitter campaign utilizing the hashtag #savejosh has also been launched to support Josh’s cause.

However, when Johnson Jr. asked Moch off camera if a visit to Josh’s bedside might help change his mind, Moch said it would not – much to the distress of Josh’s mother.

“He would see a frail little boy who has a very weak voice and has a hard time staying awake, because he’s in so much pain and to combat the pain he has to be on a lot of pain medication, so he’s drowsy,” Hardy said. “It’s horrible for us as parents to see, because he’s a vibrant, strong little boy, and even though he is frail, he has a very strong will about him. But things just keep stacking against him, and we just want to do everything we can to give him the opportunity to make a full recovery.”

To help save Josh, Hardy is encouraging supporters to call Chimerix at 919-806-1074; supporters can also e-mail compassionateuserequest@chimerix.com or tweet @chimerix using the hashtag #savejosh.

READ MORE

  • Local NewsLocal NewsMore>>

  • New York's smallest piece of private land

    New York's smallest piece of private land

    Thursday, July 31 2014 8:52 PM EDT2014-08-01 00:52:57 GMT
    The Hess triangle is a tiny piece of private property in Greenwich Village. Manhattan historian Joyce Gold explained the origins of the property: After World War I, New York City seized a beautiful residence and tore it down so it could extend Seventh Avenue and the west side subway below it. The city left the building's owner only a tiny scrap of property so small it requested he donate the triangle to make way for a sidewalk. The man refused, took the city to court and won.
    The Hess triangle is a tiny piece of private property in Greenwich Village. Manhattan historian Joyce Gold explained the origins of the property: After World War I, New York City seized a beautiful residence and tore it down so it could extend Seventh Avenue and the west side subway below it. The city left the building's owner only a tiny scrap of property so small it requested he donate the triangle to make way for a sidewalk. The man refused, took the city to court and won.
  • Runners of 3,100-mile race in Queens seek spiritual experience

    Runners of 3,100-mile race in Queens seek spiritual experience

    Thursday, July 31 2014 7:26 PM EDT2014-07-31 23:26:44 GMT
    Since mid-June, 14 runners have been on a mission that is spiritual at its core. They are running the Self-Transcendence 3,100 Mile Race in Jamaica, Queens. Spiritual leader and former Queens resident Sri Chimnoy, who died in 2007, created the race, which lasts 52 days.
    Since mid-June, 14 runners have been on a mission that is spiritual at its core. They are running the Self-Transcendence 3,100 Mile Race in Jamaica, Queens. Spiritual leader and former Queens resident Sri Chimnoy, who died in 2007, created the race, which lasts 52 days.
  • Road-trip vacations that don't break the bank

    Road-trip vacations that don't break the bank

    Thursday, July 31 2014 5:37 PM EDT2014-07-31 21:37:29 GMT
    Last-minute vacations don't need to be a headache or ridiculously expensive, especially if you make it a road trip. Even if you don't have a car, renting one can be an affordable option.Lauren Lyons Cole, a personal finance contributor to TheStreet.com, has some suggestions.
    Last-minute vacations don't need to be a headache or ridiculously expensive, especially if you make it a road trip. Even if you don't have a car, renting one can be an affordable option.Lauren Lyons Cole, a personal finance contributor to TheStreet.com, has some suggestions.
Powered by WorldNow
Didn't find what you were looking for?
All content © Copyright 2000 - 2014 Fox Television Stations, Inc. and Worldnow. All Rights Reserved.
Privacy Policy | Terms of Service | Ad Choices